Cargando…
HBV and HCV Infection in Children and Adolescents
Autores principales: | Pokorska-Śpiewak, Maria, Marczyńska, Magdalena |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9962909/ https://www.ncbi.nlm.nih.gov/pubmed/36851208 http://dx.doi.org/10.3390/vaccines11020330 |
Ejemplares similares
-
Non-Vertical Exposures to HIV, HBV and HCV Infection in Children and Adolescents—Risk of Infection, Standards of Care and Postexposure Prophylaxis
por: Tomasik, Anna, et al.
Publicado: (2021) -
The Influence of Treatment with Ledipasvir/Sofosbuvir on Growth Parameters in Children and Adolescents with Chronic Hepatitis C
por: Pokorska-Śpiewak, Maria, et al.
Publicado: (2022) -
Real-Life Experience with Ledipasvir/Sofosbuvir for the Treatment of Chronic Hepatitis C Virus Infection with Genotypes 1 and 4 in Children Aged 12 to 17 Years—Results of the POLAC Project
por: Pokorska-Śpiewak, Maria, et al.
Publicado: (2021) -
Prevalence and predictors of liver disease in HIV-infected children and adolescents
por: Pokorska-Śpiewak, Maria, et al.
Publicado: (2017) -
One-Year Outcomes after Ledipasvir/Sofosbuvir Treatment of Chronic Hepatitis C in Teenagers with and without Significant Liver Fibrosis—A Case Series Report
por: Pokorska-Śpiewak, Maria, et al.
Publicado: (2021)